| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 6.72e-07 | 25 | 137 | 5 | GO:0031683 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 2.11e-05 | 49 | 137 | 5 | GO:0005547 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.20e-04 | 70 | 137 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.64e-04 | 118 | 137 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 4.61e-04 | 5 | 137 | 2 | GO:0031821 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 2.87e-07 | 3 | 137 | 3 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 2.87e-07 | 3 | 137 | 3 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 2.87e-07 | 3 | 137 | 3 | GO:1902407 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 1.14e-06 | 4 | 137 | 3 | GO:2000689 | |
| GeneOntologyBiologicalProcess | cilium movement | CFAP251 BBS2 APOB DNAH7 KIF3A DNAAF5 CFAP54 CCNYL1 DNAH12 CFAP61 | 9.93e-06 | 261 | 137 | 10 | GO:0003341 |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 2.34e-05 | 9 | 137 | 3 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 2.34e-05 | 9 | 137 | 3 | GO:0000912 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | CFAP251 KIF23 BBS2 APOB DNAH7 KIF3A DNAAF5 CFAP54 CCNYL1 DNAH12 FMN2 KIF2A CFAP61 | 2.56e-05 | 493 | 137 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | actomyosin contractile ring organization | 3.32e-05 | 10 | 137 | 3 | GO:0044837 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 3.89e-05 | 29 | 137 | 4 | GO:0042659 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CFAP251 KIF23 RTTN BBS2 APOB DNAH7 KIF3A TUBB1 DNAAF5 CFAP54 CCNYL1 DNAH12 FMN2 GNAI1 KIF2A HOOK2 CFAP61 PARD3 PLK4 | 7.40e-05 | 1058 | 137 | 19 | GO:0007017 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 8.21e-05 | 210 | 137 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 9.67e-05 | 215 | 137 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 9.67e-05 | 215 | 137 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | negative regulation of phospholipase A2 activity | 1.31e-04 | 3 | 137 | 2 | GO:1900138 | |
| GeneOntologyBiologicalProcess | negative regulation of adenylate cyclase activity | 2.17e-04 | 18 | 137 | 3 | GO:0007194 | |
| GeneOntologyBiologicalProcess | negative regulation of cyclase activity | 2.57e-04 | 19 | 137 | 3 | GO:0031280 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 3.23e-06 | 35 | 138 | 5 | GO:0005834 | |
| GeneOntologyCellularComponent | GTPase complex | 7.22e-06 | 41 | 138 | 5 | GO:1905360 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 3.40e-05 | 56 | 138 | 5 | GO:0031234 | |
| GeneOntologyCellularComponent | radial spoke stalk | 1.29e-04 | 3 | 138 | 2 | GO:0001536 | |
| GeneOntologyCellularComponent | NuRD complex | 1.79e-04 | 17 | 138 | 3 | GO:0016581 | |
| GeneOntologyCellularComponent | CHD-type complex | 1.79e-04 | 17 | 138 | 3 | GO:0090545 | |
| GeneOntologyCellularComponent | axoneme | 4.58e-04 | 207 | 138 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 4.71e-04 | 208 | 138 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | microtubule | KIF23 IQGAP2 DNAH7 KIF3A IQGAP1 TUBB1 MTA1 DNAH12 KIF2A HOOK2 CSTPP1 | 8.34e-04 | 533 | 138 | 11 | GO:0005874 |
| HumanPheno | Achromatopsia | 1.11e-05 | 5 | 54 | 3 | HP:0011516 | |
| Domain | Gprotein_alpha_I | 1.13e-09 | 8 | 138 | 5 | IPR001408 | |
| Domain | GproteinA_insert | 8.38e-08 | 16 | 138 | 5 | IPR011025 | |
| Domain | - | 8.38e-08 | 16 | 138 | 5 | 1.10.400.10 | |
| Domain | G-alpha | 8.38e-08 | 16 | 138 | 5 | PF00503 | |
| Domain | G_alpha | 8.38e-08 | 16 | 138 | 5 | SM00275 | |
| Domain | Gprotein_alpha_su | 1.18e-07 | 17 | 138 | 5 | IPR001019 | |
| Domain | RasGAP_C | 3.95e-07 | 3 | 138 | 3 | IPR000593 | |
| Domain | RasGAP_C | 3.95e-07 | 3 | 138 | 3 | PF03836 | |
| Domain | AnnexinVIII | 5.42e-05 | 2 | 138 | 2 | IPR009115 | |
| Domain | Cyclin_Y | 5.42e-05 | 2 | 138 | 2 | IPR012399 | |
| Domain | BAH | 6.24e-05 | 11 | 138 | 3 | PS51038 | |
| Domain | BAH_dom | 6.24e-05 | 11 | 138 | 3 | IPR001025 | |
| Domain | BAH | 6.24e-05 | 11 | 138 | 3 | SM00439 | |
| Domain | BAH | 6.24e-05 | 11 | 138 | 3 | PF01426 | |
| Domain | ZnF_GATA | 8.27e-05 | 12 | 138 | 3 | SM00401 | |
| Domain | ELM2_dom | 1.07e-04 | 13 | 138 | 3 | IPR000949 | |
| Domain | ELM2 | 1.07e-04 | 13 | 138 | 3 | PF01448 | |
| Domain | ELM2 | 1.07e-04 | 13 | 138 | 3 | PS51156 | |
| Domain | ELM2 | 1.07e-04 | 13 | 138 | 3 | SM01189 | |
| Domain | Annexin | 1.35e-04 | 14 | 138 | 3 | IPR001464 | |
| Domain | RasGAP | 1.35e-04 | 14 | 138 | 3 | SM00323 | |
| Domain | RasGAP_CS | 1.35e-04 | 14 | 138 | 3 | IPR023152 | |
| Domain | - | 1.54e-04 | 207 | 138 | 8 | 1.25.40.10 | |
| Domain | RasGAP | 1.68e-04 | 15 | 138 | 3 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 1.68e-04 | 15 | 138 | 3 | PS00509 | |
| Domain | Znf_GATA | 1.68e-04 | 15 | 138 | 3 | IPR000679 | |
| Domain | GATA | 1.68e-04 | 15 | 138 | 3 | PF00320 | |
| Domain | RAS_GTPASE_ACTIV_2 | 1.68e-04 | 15 | 138 | 3 | PS50018 | |
| Domain | - | 2.06e-04 | 73 | 138 | 5 | 2.60.120.260 | |
| Domain | GATA_ZN_FINGER_1 | 2.06e-04 | 16 | 138 | 3 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 2.06e-04 | 16 | 138 | 3 | PS50114 | |
| Domain | - | 2.06e-04 | 16 | 138 | 3 | 1.10.506.10 | |
| Domain | TPR_REGION | 2.27e-04 | 165 | 138 | 7 | PS50293 | |
| Domain | TPR | 2.27e-04 | 165 | 138 | 7 | PS50005 | |
| Domain | RasGAP_dom | 2.97e-04 | 18 | 138 | 3 | IPR001936 | |
| Domain | TPR-like_helical_dom | 3.43e-04 | 233 | 138 | 8 | IPR011990 | |
| Domain | FN3 | 4.55e-04 | 185 | 138 | 7 | SM00060 | |
| Domain | P-loop_NTPase | KIF23 ABCA13 DCK DNAH7 KIF3A IQGAP1 DNAH12 RAB30 GPN2 GNAT3 GNAI1 GNAI2 KIF2A GNAI3 GNAT2 MYO15A | 5.33e-04 | 848 | 138 | 16 | IPR027417 |
| Domain | TPR_1 | 5.44e-04 | 90 | 138 | 5 | IPR001440 | |
| Domain | TPR_1 | 5.44e-04 | 90 | 138 | 5 | PF00515 | |
| Domain | TPR_8 | 6.31e-04 | 53 | 138 | 4 | PF13181 | |
| Domain | Galactose-bd-like | 6.64e-04 | 94 | 138 | 5 | IPR008979 | |
| Domain | FN3 | 7.01e-04 | 199 | 138 | 7 | PS50853 | |
| Domain | TPR-contain_dom | 8.74e-04 | 150 | 138 | 6 | IPR013026 | |
| Domain | SANT_dom | 9.06e-04 | 26 | 138 | 3 | IPR017884 | |
| Domain | FN3_dom | 9.35e-04 | 209 | 138 | 7 | IPR003961 | |
| Domain | SANT | 1.13e-03 | 28 | 138 | 3 | PS51293 | |
| Domain | CH | 1.36e-03 | 65 | 138 | 4 | SM00033 | |
| Domain | CH | 1.79e-03 | 70 | 138 | 4 | PF00307 | |
| Domain | MYTH4 | 1.89e-03 | 9 | 138 | 2 | PS51016 | |
| Domain | MyTH4 | 1.89e-03 | 9 | 138 | 2 | SM00139 | |
| Domain | MyTH4_dom | 1.89e-03 | 9 | 138 | 2 | IPR000857 | |
| Domain | MyTH4 | 1.89e-03 | 9 | 138 | 2 | PF00784 | |
| Domain | IQ | 1.89e-03 | 71 | 138 | 4 | PF00612 | |
| Domain | - | 1.89e-03 | 71 | 138 | 4 | 1.10.418.10 | |
| Domain | CH | 2.09e-03 | 73 | 138 | 4 | PS50021 | |
| Domain | Myb_DNA-binding | 2.17e-03 | 35 | 138 | 3 | PF00249 | |
| Domain | CH-domain | 2.31e-03 | 75 | 138 | 4 | IPR001715 | |
| Domain | TPR | 2.71e-03 | 129 | 138 | 5 | SM00028 | |
| Domain | MYB_LIKE | 2.76e-03 | 38 | 138 | 3 | PS50090 | |
| Domain | IQ | 3.06e-03 | 81 | 138 | 4 | SM00015 | |
| Domain | TPR_repeat | 3.09e-03 | 133 | 138 | 5 | IPR019734 | |
| Domain | Kinesin_motor_CS | 3.43e-03 | 41 | 138 | 3 | IPR019821 | |
| Domain | ARM-type_fold | 3.74e-03 | 339 | 138 | 8 | IPR016024 | |
| Domain | Kinesin-like_fam | 3.92e-03 | 43 | 138 | 3 | IPR027640 | |
| Domain | ARM-like | 3.97e-03 | 270 | 138 | 7 | IPR011989 | |
| Domain | Kelch_2 | 4.01e-03 | 13 | 138 | 2 | IPR011498 | |
| Domain | ANX | 4.01e-03 | 13 | 138 | 2 | SM00335 | |
| Domain | Annexin_repeat_CS | 4.01e-03 | 13 | 138 | 2 | IPR018252 | |
| Domain | Annexin | 4.01e-03 | 13 | 138 | 2 | PF00191 | |
| Domain | Annexin_repeat | 4.01e-03 | 13 | 138 | 2 | IPR018502 | |
| Domain | Kelch_2 | 4.01e-03 | 13 | 138 | 2 | PF07646 | |
| Domain | ANNEXIN | 4.01e-03 | 13 | 138 | 2 | PS00223 | |
| Domain | - | 4.01e-03 | 13 | 138 | 2 | 1.10.220.10 | |
| Domain | Rho_GTPase_activation_prot | 4.12e-03 | 88 | 138 | 4 | IPR008936 | |
| Domain | - | 4.19e-03 | 44 | 138 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 4.19e-03 | 44 | 138 | 3 | PF00225 | |
| Domain | KISc | 4.19e-03 | 44 | 138 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 4.19e-03 | 44 | 138 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 4.19e-03 | 44 | 138 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 4.19e-03 | 44 | 138 | 3 | PS50067 | |
| Domain | IQ_motif_EF-hand-BS | 4.46e-03 | 90 | 138 | 4 | IPR000048 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 4.65e-03 | 14 | 138 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 4.65e-03 | 14 | 138 | 2 | PS00790 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.65e-03 | 14 | 138 | 2 | IPR024317 | |
| Domain | Tyr_kinase_rcpt_V_CS | 4.65e-03 | 14 | 138 | 2 | IPR001426 | |
| Domain | Dynein_heavy_dom-2 | 4.65e-03 | 14 | 138 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.65e-03 | 14 | 138 | 2 | PF08393 | |
| Domain | EphA2_TM | 4.65e-03 | 14 | 138 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 4.65e-03 | 14 | 138 | 2 | IPR001090 | |
| Domain | Eph_TM | 4.65e-03 | 14 | 138 | 2 | IPR027936 | |
| Domain | EPH_lbd | 4.65e-03 | 14 | 138 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 4.65e-03 | 14 | 138 | 2 | PF01404 | |
| Domain | AAA_8 | 4.65e-03 | 14 | 138 | 2 | PF12780 | |
| Domain | Tyr_kinase_ephrin_rcpt | 4.65e-03 | 14 | 138 | 2 | IPR016257 | |
| Domain | EPH_LBD | 4.65e-03 | 14 | 138 | 2 | PS51550 | |
| Domain | SET | 4.75e-03 | 46 | 138 | 3 | SM00317 | |
| Domain | IQ | 5.01e-03 | 93 | 138 | 4 | PS50096 | |
| Domain | DHC_fam | 5.34e-03 | 15 | 138 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 5.34e-03 | 15 | 138 | 2 | PF03028 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 2.45e-06 | 14 | 102 | 4 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 2.45e-06 | 14 | 102 | 4 | M750 | |
| Pathway | WP_PURINERGIC_SIGNALING | 3.63e-06 | 33 | 102 | 5 | M39855 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 1.71e-05 | 22 | 102 | 4 | MM15016 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 1.71e-05 | 22 | 102 | 4 | M841 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.01e-05 | 8 | 102 | 3 | M47642 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.01e-05 | 8 | 102 | 3 | M47643 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 2.06e-05 | 23 | 102 | 4 | MM15952 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY | 2.99e-05 | 9 | 102 | 3 | M47641 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 5.34e-05 | 29 | 102 | 4 | MM15219 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 5.82e-05 | 11 | 102 | 3 | M47797 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 6.74e-05 | 189 | 102 | 8 | MM15356 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 7.00e-05 | 31 | 102 | 4 | M213 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 7.61e-05 | 98 | 102 | 6 | MM15352 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 7.72e-05 | 12 | 102 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 7.72e-05 | 12 | 102 | 3 | M47559 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 7.95e-05 | 32 | 102 | 4 | M27491 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 8.52e-05 | 100 | 102 | 6 | M27650 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 9.00e-05 | 33 | 102 | 4 | MM15020 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 9.00e-05 | 33 | 102 | 4 | M9379 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 1.11e-04 | 203 | 102 | 8 | M27654 | |
| Pathway | PID_S1P_S1P4_PATHWAY | 1.26e-04 | 14 | 102 | 3 | M64 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.75e-04 | 39 | 102 | 4 | MM14496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.32e-04 | 17 | 102 | 3 | M47544 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 2.57e-04 | 43 | 102 | 4 | M29837 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.57e-04 | 43 | 102 | 4 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.81e-04 | 44 | 102 | 4 | MM15709 | |
| Pathway | REACTOME_GPER1_SIGNALING | 3.06e-04 | 45 | 102 | 4 | M45008 | |
| Pathway | KEGG_AXON_GUIDANCE | 3.43e-04 | 129 | 102 | 6 | M5539 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION | 3.63e-04 | 47 | 102 | 4 | M1095 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | 3.63e-04 | 47 | 102 | 4 | MM15428 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 3.73e-04 | 131 | 102 | 6 | MM15497 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 3.94e-04 | 48 | 102 | 4 | M219 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 3.94e-04 | 48 | 102 | 4 | M10775 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 4.21e-04 | 134 | 102 | 6 | M27751 | |
| Pathway | PID_S1P_S1P1_PATHWAY | 4.45e-04 | 21 | 102 | 3 | M103 | |
| Pathway | PID_S1P_META_PATHWAY | 4.45e-04 | 21 | 102 | 3 | M155 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 6.19e-04 | 54 | 102 | 4 | M26911 | |
| Pathway | PID_S1P_S1P2_PATHWAY | 6.67e-04 | 24 | 102 | 3 | M268 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 7.53e-04 | 25 | 102 | 3 | M39384 | |
| Pathway | REACTOME_KINESINS | 7.60e-04 | 57 | 102 | 4 | MM15714 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | VRK2 IQGAP2 CENPU ARHGAP39 MUC13 AR IQGAP1 HNRNPCL3 TUBB1 EPHA2 KIF2A SCFD1 IQGAP3 | 7.95e-04 | 649 | 102 | 13 | MM15690 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 8.47e-04 | 26 | 102 | 3 | M47553 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 9.23e-04 | 60 | 102 | 4 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 9.23e-04 | 60 | 102 | 4 | M976 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 9.48e-04 | 27 | 102 | 3 | MM15537 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 9.48e-04 | 27 | 102 | 3 | M47519 | |
| Pathway | REACTOME_KINESINS | 9.83e-04 | 61 | 102 | 4 | M977 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 1.17e-03 | 29 | 102 | 3 | M55 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION | 1.43e-03 | 31 | 102 | 3 | M48258 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.69e-03 | 175 | 102 | 6 | MM15599 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.73e-03 | 71 | 102 | 4 | MM14491 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 1.73e-03 | 71 | 102 | 4 | MM15590 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.73e-03 | 71 | 102 | 4 | MM15604 | |
| Pathway | WP_AXON_GUIDANCE | 1.82e-03 | 72 | 102 | 4 | M48335 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 2.02e-03 | 74 | 102 | 4 | M41814 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 2.12e-03 | 75 | 102 | 4 | M27874 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.18e-03 | 184 | 102 | 6 | M41809 | |
| Pathway | WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA | 2.39e-03 | 37 | 102 | 3 | M39756 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 2.39e-03 | 37 | 102 | 3 | M42558 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.45e-03 | 254 | 102 | 7 | M27131 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 2.62e-03 | 257 | 102 | 7 | MM14755 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP | 2.73e-03 | 11 | 102 | 2 | M47820 | |
| Pubmed | The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. | 2.44e-10 | 10 | 140 | 5 | 8521505 | |
| Pubmed | Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. | 1.23e-09 | 13 | 140 | 5 | 8208289 | |
| Pubmed | Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. | 1.23e-09 | 13 | 140 | 5 | 16892066 | |
| Pubmed | 2.86e-09 | 15 | 140 | 5 | 11118617 | ||
| Pubmed | 3.75e-09 | 6 | 140 | 4 | 25078664 | ||
| Pubmed | 3.75e-09 | 6 | 140 | 4 | 30975754 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 16962188 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 25722290 | ||
| Pubmed | Involvement of IQGAP family proteins in the regulation of mammalian cell cytokinesis. | 6.38e-08 | 3 | 140 | 3 | 25229330 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 29342363 | ||
| Pubmed | Identification and characterization of metastasis-associated gene/protein 1 (MTA1). | 6.38e-08 | 3 | 140 | 3 | 25315816 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 26869315 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 30836096 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 15788486 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 17484771 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 22493426 | ||
| Pubmed | A molecular blueprint at the apical surface establishes planar asymmetry in cochlear hair cells. | 1.75e-07 | 13 | 140 | 4 | 24135232 | |
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 17635935 | ||
| Pubmed | Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. | 2.55e-07 | 4 | 140 | 3 | 11248120 | |
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 11771389 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 28970065 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 11168387 | ||
| Pubmed | The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. | 2.55e-07 | 4 | 140 | 3 | 18832081 | |
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 21931697 | ||
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 28145731 | ||
| Pubmed | 6.12e-07 | 75 | 140 | 6 | 25593309 | ||
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 12860983 | ||
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 26373672 | ||
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 16298104 | ||
| Pubmed | Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. | 6.35e-07 | 5 | 140 | 3 | 2820999 | |
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 22230296 | ||
| Pubmed | Coupling of dopamine receptor subtypes to multiple and diverse G proteins. | 6.35e-07 | 5 | 140 | 3 | 10978845 | |
| Pubmed | Defective macrophage migration in Gαi2- but not Gαi3-deficient mice. | 6.35e-07 | 5 | 140 | 3 | 22706085 | |
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 31036553 | ||
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 11387333 | ||
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 24415754 | ||
| Pubmed | Identification of the platelet ADP receptor targeted by antithrombotic drugs. | 1.27e-06 | 6 | 140 | 3 | 11196645 | |
| Pubmed | 1.27e-06 | 6 | 140 | 3 | 16371464 | ||
| Pubmed | Cloning and characterization of a novel regulator of G protein signalling in human platelets. | 1.27e-06 | 6 | 140 | 3 | 11955952 | |
| Pubmed | 1.27e-06 | 6 | 140 | 3 | 23236180 | ||
| Pubmed | 1.27e-06 | 6 | 140 | 3 | 19401591 | ||
| Pubmed | Characterization of RGS5 in regulation of G protein-coupled receptor signaling. | 1.27e-06 | 6 | 140 | 3 | 11253162 | |
| Pubmed | MTA2 KCTD12 KIF23 NAA15 IQGAP2 GTF3C3 IQGAP1 TELO2 SCFD1 IMMT NSMAF | 1.73e-06 | 437 | 140 | 11 | 20562859 | |
| Pubmed | MTA2 NAA15 RRM1 THOC2 GTF3C3 IQGAP1 DNAAF5 TELO2 KIF2A PSME3 SCFD1 IMMT HNRNPR | 2.02e-06 | 638 | 140 | 13 | 33239621 | |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 15251452 | ||
| Pubmed | Activation state-dependent interaction between Galphai and p67phox. | 2.21e-06 | 7 | 140 | 3 | 16782902 | |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 33162027 | ||
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 8986788 | ||
| Pubmed | 2.51e-06 | 24 | 140 | 4 | 2902634 | ||
| Pubmed | 3.52e-06 | 8 | 140 | 3 | 18067919 | ||
| Pubmed | Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor. | 3.52e-06 | 8 | 140 | 3 | 12509430 | |
| Pubmed | The mutational landscape of lethal castration-resistant prostate cancer. | 3.52e-06 | 8 | 140 | 3 | 22722839 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | KIF23 NAA15 ANXA8L1 CENPU ANXA8 GTF3C3 IQGAP1 NBAS MICALL2 GNAT3 GNAI1 GNAI2 GNAI3 GNAT2 PLK4 IQGAP3 HNRNPR | 4.33e-06 | 1155 | 140 | 17 | 20360068 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 4.72e-06 | 231 | 140 | 8 | 36597993 | |
| Pubmed | 4.78e-06 | 28 | 140 | 4 | 8858601 | ||
| Pubmed | 4.78e-06 | 28 | 140 | 4 | 24861553 | ||
| Pubmed | Inhibitory G proteins play multiple roles to polarize sensory hair cell morphogenesis. | 5.27e-06 | 9 | 140 | 3 | 38651641 | |
| Pubmed | RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene. | 5.27e-06 | 9 | 140 | 3 | 22926524 | |
| Pubmed | GPSM2-GNAI Specifies the Tallest Stereocilia and Defines Hair Bundle Row Identity. | 5.27e-06 | 9 | 140 | 3 | 30827920 | |
| Pubmed | 5.27e-06 | 9 | 140 | 3 | 26028330 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 5.51e-06 | 400 | 140 | 10 | 35013556 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | VRK2 NAA15 INTS8 GTF3C3 COG8 IQGAP1 DNAAF5 ATF6 TELO2 EPHA2 NUS1 SCFD1 KLHDC4 IMMT IQGAP3 | 6.53e-06 | 942 | 140 | 15 | 31073040 |
| Pubmed | PWWP2B Fine-Tunes Adipose Thermogenesis by Stabilizing HDACs in a NuRD Subcomplex. | 7.50e-06 | 10 | 140 | 3 | 34180153 | |
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 26755700 | ||
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 8552586 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MTA2 KIF23 NAA15 MAP4K3 CGAS RRM1 DCK GTF3C3 IQGAP1 GTF2H4 UTP4 GNAI2 KIF2A PSME3 SCFD1 PARD3 IMMT HNRNPR | 8.88e-06 | 1353 | 140 | 18 | 29467282 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MTA2 KIF23 NAA15 CGAS THOC2 GTF3C3 IQGAP1 GTF2H4 MTA3 UTP4 GNAI1 GNAI2 KIF2A GNAI3 IMMT IQGAP3 HNRNPR | 1.30e-05 | 1257 | 140 | 17 | 36526897 |
| Pubmed | Diversity of the G-protein family: sequences from five additional alpha subunits in the mouse. | 1.37e-05 | 12 | 140 | 3 | 2508088 | |
| Pubmed | 1.37e-05 | 12 | 140 | 3 | 20720167 | ||
| Pubmed | 1.37e-05 | 12 | 140 | 3 | 22560079 | ||
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 1.37e-05 | 12 | 140 | 3 | 9611134 | |
| Pubmed | IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. | 1.37e-05 | 12 | 140 | 3 | 18604197 | |
| Pubmed | RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of galphao. | 1.37e-05 | 12 | 140 | 3 | 10926822 | |
| Pubmed | KIF23 CGAS THOC2 CCNY IQGAP1 EPHA2 UTP4 GNAI2 KIF2A GNAI3 IMMT HNRNPR | 1.58e-05 | 660 | 140 | 12 | 32780723 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KIF23 ARHGAP39 THOC2 CCNY IQGAP1 MTA1 LATS1 CCNYL1 KMT2A SCFD1 PARD3 KLHDC4 KDM6A | 1.60e-05 | 774 | 140 | 13 | 15302935 |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 1364010 | ||
| Pubmed | MAP4K3/GLK Promotes Lung Cancer Metastasis by Phosphorylating and Activating IQGAP1. | 1.61e-05 | 2 | 140 | 2 | 31431460 | |
| Pubmed | Platelet Gi protein Gαi2 is an essential mediator of thrombo-inflammatory organ damage in mice. | 1.61e-05 | 2 | 140 | 2 | 25944935 | |
| Pubmed | Gαi2 and Gαi3 Differentially Regulate Arrest from Flow and Chemotaxis in Mouse Neutrophils. | 1.61e-05 | 2 | 140 | 2 | 26976957 | |
| Pubmed | Cooperative binding promotes demand-driven recruitment of AnxA8 to cholesterol-containing membranes. | 1.61e-05 | 2 | 140 | 2 | 29306076 | |
| Pubmed | Gi and RGS proteins provide biochemical control of androgen receptor nuclear exclusion. | 1.61e-05 | 2 | 140 | 2 | 17416965 | |
| Pubmed | Bone matrix regulates osteoclast differentiation and annexin A8 gene expression. | 1.61e-05 | 2 | 140 | 2 | 21344395 | |
| Pubmed | Gαi2- and Gαi3-deficient mice display opposite severity of myocardial ischemia reperfusion injury. | 1.61e-05 | 2 | 140 | 2 | 24858945 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 16203777 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 37010644 | ||
| Pubmed | A small multigene family encodes Gi signal-transduction proteins. | 1.61e-05 | 2 | 140 | 2 | 3120178 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 31943016 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11917092 | ||
| Pubmed | Visualising androgen receptor activity in male and female mice. | 1.61e-05 | 2 | 140 | 2 | 23940781 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 10725232 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27989506 | ||
| Pubmed | Inhibition of MTA2 and MTA3 induces mesendoderm specification of human embryonic stem cells. | 1.61e-05 | 2 | 140 | 2 | 33744762 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 33754034 | ||
| Pubmed | MTA1 promotes viability and motility in nasopharyngeal carcinoma by modulating IQGAP1 expression. | 1.61e-05 | 2 | 140 | 2 | 29125886 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 17360531 | ||
| Pubmed | REGγ Controls Hippo Signaling and Reciprocal NF-κB-YAP Regulation to Promote Colon Cancer. | 1.61e-05 | 2 | 140 | 2 | 29437787 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 29073199 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24769558 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24998570 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19363681 | ||
| Interaction | USP54 interactions | 2.34e-06 | 212 | 140 | 10 | int:USP54 | |
| Interaction | RHOC interactions | VRK2 KIF23 ARHGAP39 MUC13 IQGAP1 EPHA2 HPRT1 NUS1 KMT2A GNAI2 GNAI3 SCFD1 PARD3 CLEC16A IMMT IQGAP3 | 3.11e-06 | 584 | 140 | 16 | int:RHOC |
| GeneFamily | PHD finger proteins|NuRD complex | 2.07e-05 | 12 | 84 | 3 | 1305 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.23e-05 | 15 | 84 | 3 | 82 | |
| GeneFamily | Fibronectin type III domain containing | 8.97e-04 | 160 | 84 | 5 | 555 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.27e-03 | 46 | 84 | 3 | 622 | |
| GeneFamily | Annexins|Endogenous ligands | 1.61e-03 | 13 | 84 | 2 | 404 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.87e-03 | 14 | 84 | 2 | 1095 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.92e-03 | 53 | 84 | 3 | 532 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.03e-03 | 115 | 84 | 4 | 769 | |
| GeneFamily | Dyneins, axonemal | 2.77e-03 | 17 | 84 | 2 | 536 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.77e-03 | 17 | 84 | 2 | 1197 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 5.97e-03 | 25 | 84 | 2 | 565 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.73e-03 | 161 | 84 | 4 | 593 | |
| GeneFamily | Cyclins | 7.45e-03 | 28 | 84 | 2 | 473 | |
| GeneFamily | WD repeat domain containing | 7.50e-03 | 262 | 84 | 5 | 362 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.09e-02 | 34 | 84 | 2 | 487 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 184 | 140 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 184 | 140 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 184 | 140 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.10e-08 | 159 | 140 | 8 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.16e-07 | 182 | 140 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-07 | 184 | 140 | 8 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.32e-07 | 185 | 140 | 8 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 1.49e-07 | 188 | 140 | 8 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.49e-07 | 188 | 140 | 8 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.56e-07 | 189 | 140 | 8 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-07 | 200 | 140 | 8 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-07 | 200 | 140 | 8 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.39e-06 | 175 | 140 | 7 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-06 | 176 | 140 | 7 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-06 | 178 | 140 | 7 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-06 | 179 | 140 | 7 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-06 | 185 | 140 | 7 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.01e-06 | 185 | 140 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.16e-06 | 187 | 140 | 7 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.24e-06 | 188 | 140 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 2.32e-06 | 189 | 140 | 7 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.32e-06 | 189 | 140 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.32e-06 | 189 | 140 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.32e-06 | 189 | 140 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.48e-06 | 191 | 140 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.48e-06 | 191 | 140 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.48e-06 | 191 | 140 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.57e-06 | 192 | 140 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.66e-06 | 193 | 140 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.66e-06 | 193 | 140 | 7 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-06 | 194 | 140 | 7 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.75e-06 | 194 | 140 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.85e-06 | 195 | 140 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-06 | 195 | 140 | 7 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.85e-06 | 195 | 140 | 7 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.85e-06 | 195 | 140 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.85e-06 | 195 | 140 | 7 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.95e-06 | 196 | 140 | 7 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.95e-06 | 196 | 140 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.15e-06 | 198 | 140 | 7 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-06 | 143 | 140 | 6 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-7|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 6.64e-06 | 145 | 140 | 6 | 88090a226ddfa6df59976f025bf0fd84ca0f72ef | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Npnt_(Retrosplenial_areas,_layer_5,_Npnt+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.32e-06 | 41 | 140 | 4 | b1e70962de91a747ec718a3fad4247fd0cb7d9a8 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Npnt_(Retrosplenial_areas,_layer_5,_Npnt+)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.32e-06 | 41 | 140 | 4 | 16dbb13baa47c4db80ddd83ac36aad6c43b5461a | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 170 | 140 | 6 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 171 | 140 | 6 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-05 | 172 | 140 | 6 | e39ea2f4edbf36ebf9604fa6f9349081859c596c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-05 | 172 | 140 | 6 | 875ea290840e835952623b905eb610f3c71456d2 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-05 | 172 | 140 | 6 | bcc50bed47465daa953ba91f17d1ee4c947ab461 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 172 | 140 | 6 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.82e-05 | 173 | 140 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-05 | 176 | 140 | 6 | 867936a20f73f638055c19c8d88834aa2cc657cf | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 2.00e-05 | 176 | 140 | 6 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.07e-05 | 177 | 140 | 6 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.13e-05 | 178 | 140 | 6 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 181 | 140 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.42e-05 | 182 | 140 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-05 | 187 | 140 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.99e-05 | 189 | 140 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 190 | 140 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.08e-05 | 190 | 140 | 6 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.08e-05 | 190 | 140 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Ebf1_(Anterior_pretectal_nucleus_(APT))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.12e-05 | 57 | 140 | 4 | ef44602342511a9f90c93463628ad8b154cb26fb | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Ebf1_(Anterior_pretectal_nucleus_(APT))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.12e-05 | 57 | 140 | 4 | a3dc14f7a63cc70b2789770644e0b9453426c6f9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-05 | 191 | 140 | 6 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.26e-05 | 192 | 140 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 3.26e-05 | 192 | 140 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 193 | 140 | 6 | ac4270b26f5dc7ff2220a109e5aae5a113893211 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.36e-05 | 193 | 140 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 193 | 140 | 6 | 7a09739d0b07dcd615cce2da93fd169cc92e566d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-05 | 194 | 140 | 6 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-05 | 194 | 140 | 6 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.46e-05 | 194 | 140 | 6 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-05 | 194 | 140 | 6 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-05 | 195 | 140 | 6 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 3.56e-05 | 195 | 140 | 6 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.66e-05 | 196 | 140 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.66e-05 | 196 | 140 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.66e-05 | 196 | 140 | 6 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-05 | 197 | 140 | 6 | 861e8df9bd74dc5e17bafdc1fb3fef546753c73a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.76e-05 | 197 | 140 | 6 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.76e-05 | 197 | 140 | 6 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.76e-05 | 197 | 140 | 6 | bd9d57e0c873f6526dca322f4dad8e6bd692586c | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 3.76e-05 | 197 | 140 | 6 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 3.87e-05 | 198 | 140 | 6 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.87e-05 | 198 | 140 | 6 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.87e-05 | 198 | 140 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-05 | 199 | 140 | 6 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-05 | 199 | 140 | 6 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-05 | 199 | 140 | 6 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.98e-05 | 199 | 140 | 6 | 994e885b8d1874006302a081d13f1ee881d64612 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.98e-05 | 199 | 140 | 6 | f965eb89d6d023c83154276b8fded490fd89c100 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-05 | 199 | 140 | 6 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | Biopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.98e-05 | 199 | 140 | 6 | d73667e2e93026d95184e24ff0bc90afd1fb74a9 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-05 | 199 | 140 | 6 | be425e9cb90a73289026b1b7cb581e1c02a8985e | |
| ToppCell | Transverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 3.98e-05 | 199 | 140 | 6 | 170ae68963d31f3b821b6f0e8f0c039bea0bc981 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.10e-05 | 200 | 140 | 6 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.10e-05 | 200 | 140 | 6 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.10e-05 | 200 | 140 | 6 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Vipr2_(central_amygdaloid_nucleus,_medial_division,_anterodorsal_part_(CeMAD))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.57e-05 | 66 | 140 | 4 | 6db3933fde0eee67dc5da85d7008c4fef9f684f5 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 1.07e-10 | 8 | 136 | 5 | DOID:1858 (implicated_via_orthology) | |
| Disease | Monochromatopsia | 2.09e-04 | 5 | 136 | 2 | C0751043 | |
| Disease | Color Blindness, Inherited | 2.09e-04 | 5 | 136 | 2 | C0751042 | |
| Disease | Color blindness | 2.09e-04 | 5 | 136 | 2 | C0242225 | |
| Disease | Color vision defect | 2.09e-04 | 5 | 136 | 2 | C0009398 | |
| Disease | Color Blindness, Red | 2.09e-04 | 5 | 136 | 2 | C0155015 | |
| Disease | Color Blindness, Red-Green | 2.09e-04 | 5 | 136 | 2 | C0155016 | |
| Disease | Color Blindness, Acquired | 2.09e-04 | 5 | 136 | 2 | C0155018 | |
| Disease | Color Blindness, Green | 2.09e-04 | 5 | 136 | 2 | C0239777 | |
| Disease | Color Blindness, Blue | 3.13e-04 | 6 | 136 | 2 | C0155017 | |
| Disease | allergic disease, age at onset | 3.30e-04 | 71 | 136 | 4 | EFO_0004847, MONDO_0005271 | |
| Disease | Achromatopsia | 4.36e-04 | 7 | 136 | 2 | C0152200 | |
| Disease | Nonsyndromic Deafness | 5.46e-04 | 81 | 136 | 4 | C3711374 | |
| Disease | Liver carcinoma | 5.93e-04 | 507 | 136 | 9 | C2239176 | |
| Disease | liver fibrosis measurement | 6.84e-04 | 86 | 136 | 4 | EFO_0010576 | |
| Disease | obesity (is_implicated_in) | 8.46e-04 | 91 | 136 | 4 | DOID:9970 (is_implicated_in) | |
| Disease | volumetric bone mineral density | 9.64e-04 | 42 | 136 | 3 | EFO_0007620 | |
| Disease | insomnia measurement | 1.07e-03 | 443 | 136 | 8 | EFO_0007876 | |
| Disease | Alzheimer disease, APOE carrier status | 1.12e-03 | 98 | 136 | 4 | EFO_0007659, MONDO_0004975 | |
| Disease | phosphatidylcholine 32:0 measurement | 1.13e-03 | 11 | 136 | 2 | EFO_0010372 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.25e-03 | 101 | 136 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | allergic disease | 1.29e-03 | 258 | 136 | 6 | MONDO_0005271 | |
| Disease | cardiovascular disease | 1.31e-03 | 457 | 136 | 8 | EFO_0000319 | |
| Disease | treatment-resistant hypertension | 1.65e-03 | 109 | 136 | 4 | EFO_1002006 | |
| Disease | femoral neck bone geometry | 1.85e-03 | 14 | 136 | 2 | EFO_0004511 | |
| Disease | Body Weight | 2.13e-03 | 15 | 136 | 2 | C0005910 | |
| Disease | unipolar depression, autism spectrum disorder | 2.13e-03 | 15 | 136 | 2 | EFO_0003756, EFO_0003761 | |
| Disease | hemorheological measurement | 2.13e-03 | 15 | 136 | 2 | EFO_0803374 | |
| Disease | response to vaccine | 2.49e-03 | 122 | 136 | 4 | EFO_0004645 | |
| Disease | cystatin C measurement | 2.69e-03 | 402 | 136 | 7 | EFO_0004617 | |
| Disease | Tactile Amnesia | 2.74e-03 | 17 | 136 | 2 | C0750906 | |
| Disease | Amnestic State | 2.74e-03 | 17 | 136 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 2.74e-03 | 17 | 136 | 2 | C0236795 | |
| Disease | Hysterical amnesia | 2.74e-03 | 17 | 136 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 2.74e-03 | 17 | 136 | 2 | C0233796 | |
| Disease | Amnesia | 2.74e-03 | 17 | 136 | 2 | C0002622 | |
| Disease | Global Amnesia | 2.74e-03 | 17 | 136 | 2 | C0262497 | |
| Disease | docosahexaenoic acid measurement | 2.88e-03 | 127 | 136 | 4 | EFO_0007761 | |
| Disease | Carcinoma of bladder | 3.07e-03 | 18 | 136 | 2 | C0699885 | |
| Disease | hair color | 3.27e-03 | 311 | 136 | 6 | EFO_0003924 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 3.43e-03 | 19 | 136 | 2 | EFO_0802076 | |
| Disease | cannabis dependence | 3.59e-03 | 135 | 136 | 4 | EFO_0007191 | |
| Disease | exercise test | 3.79e-03 | 20 | 136 | 2 | EFO_0004328 | |
| Disease | unipolar depression | VRK2 ABCA13 OLFM4 DNAH7 NBAS PTPRD MTA3 SORCS3 KIF2A GNAI3 CFAP61 CTNND2 PARD3 | 3.87e-03 | 1206 | 136 | 13 | EFO_0003761 |
| Disease | nephrotic syndrome | 4.35e-03 | 71 | 136 | 3 | EFO_0004255 | |
| Disease | p-tau measurement | 4.53e-03 | 72 | 136 | 3 | EFO_0004763 | |
| Disease | progression free survival, ovarian serous carcinoma | 4.59e-03 | 22 | 136 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | Primary microcephaly | 4.59e-03 | 22 | 136 | 2 | C0431350 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 4.59e-03 | 22 | 136 | 2 | EFO_0009312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YANYFIRLLEIQADY | 231 | Q6ZT62 | |
| DRVYEELNIYSATYS | 216 | Q01362 | |
| LLSSYTDYLLDNYQV | 2751 | Q96N23 | |
| YDENLITDLYSYFTE | 1131 | Q8NHU2 | |
| RYADLYAASFINLLY | 456 | P49902 | |
| YSYYAQNEVVATDDL | 546 | Q8IUX7 | |
| YARTDNLSSYNEAFF | 5896 | Q8WXG9 | |
| YSDAYDIFQIIELYN | 221 | A6NJG6 | |
| ENNFLDYYVAYLRDL | 351 | A8MVX0 | |
| YFLSNLKQLYQDYSD | 356 | Q71F23 | |
| SSFYRYIYELLNIQS | 966 | Q86UQ4 | |
| ELQVYYASPRSYQDF | 541 | P18850 | |
| YAKYYFDLRSLAEAN | 271 | Q8ND76 | |
| TNYFYDVEALRDYLL | 46 | Q9NW81 | |
| ESLRSNDLNYFFYFT | 276 | Q9H7Y0 | |
| RIQLEEYSNTRAYYF | 236 | Q8N884 | |
| YAKYYFDLRSLADDN | 291 | Q8N7R7 | |
| NYVDFYSAARPYSEL | 1196 | Q9UQB3 | |
| KQLYEYLFNATRSYA | 601 | Q2TB18 | |
| LSNVAYEDDYYSNTL | 821 | Q9UPM8 | |
| LEDYFYYSQLRSQGI | 956 | Q8TBY9 | |
| IFTLYNYASNQREEY | 1006 | P46940 | |
| VLYLYFSNYLQIDEE | 81 | Q9BUV8 | |
| YRAFLQYLYTDTVDL | 421 | Q8NDN9 | |
| YVYFENSSSNPYLVR | 11 | O94776 | |
| QSYYRSANALILTYD | 76 | Q15771 | |
| ELFDPNTSRFYYYNA | 71 | Q9C0H5 | |
| NRSREYQLNDSAAYY | 141 | P63096 | |
| YQLNDSAAYYLNDLD | 146 | P63096 | |
| DIYFATNQYSAALHY | 841 | Q75QN2 | |
| YRDYSGLLYLNDDFQ | 606 | Q8IVL6 | |
| TQNLHSYFAERLYYA | 251 | P13928 | |
| YYTARSNLDLQLEYG | 366 | Q8IVH8 | |
| DNYLYLQELASIYSL | 146 | Q8N4N3 | |
| ERASEYQLNDSAAYY | 141 | A8MTJ3 | |
| YQLNDSAAYYLNDLD | 146 | A8MTJ3 | |
| FNLDYYTEVLDLSYL | 191 | Q9H9Y4 | |
| SRSREYQLNDSASYY | 141 | P08754 | |
| YQLNDSASYYLNDLD | 146 | P08754 | |
| VRLYYSFQDKDNLYF | 766 | O95835 | |
| AFSLQEAETYYYLNQ | 1426 | Q9UKN7 | |
| GSSFDLDYNLQRDYY | 106 | B7ZW38 | |
| TYGNFDSQSRRYYFL | 166 | Q96ED9 | |
| TTYEEYQAQRYEAAS | 581 | Q9NR71 | |
| QELLNDYRYRSYSSV | 6 | Q9Y3R5 | |
| KALSAYQRYYSLQSD | 111 | O15550 | |
| TFNLYYYESDNDKER | 121 | P54764 | |
| DRLSILTYVSQYYNY | 91 | Q8IY33 | |
| QNQYSTIDFDFLRYA | 351 | Q9NVF9 | |
| SYNNASNDTYLYRVQ | 51 | Q9H114 | |
| NISYEDFFSALRQYA | 271 | Q96E22 | |
| AARQASRSTAYEDYY | 421 | O43390 | |
| VRNSYYEEALELAAY | 166 | Q96MW5 | |
| RYLNDHFTYNLYCNI | 2321 | Q6ZR08 | |
| RNRPSFDAILYYYQS | 151 | P22001 | |
| TRNSLYQYFLSYLQS | 651 | Q16891 | |
| AYDFLYNYLSKTQQE | 161 | Q9UL01 | |
| GSSFDLDYNLQRDYY | 106 | P0DMR1 | |
| RISAEAFYYLVELQY | 71 | Q3SXY7 | |
| AAAYQSRDYYNFPLA | 356 | P10275 | |
| ANFAYDPSNYEYLRQ | 41 | Q9H6L4 | |
| ENGYLYALRSFDYEQ | 521 | Q9P2E7 | |
| DYNYDETISTLRYAN | 326 | Q9Y496 | |
| DYSAYYRQIEELRSQ | 116 | P35900 | |
| LQLAAYYYSLQIYAR | 1571 | A2RRP1 | |
| FSLYNYASSRREAYL | 991 | Q86VI3 | |
| DYEYSELLLYQNQVL | 186 | Q9BXJ9 | |
| NSRENRLEYYSFYQS | 561 | Q7Z2Q7 | |
| RQEVISYYSQYSLDE | 186 | Q8N485 | |
| YALDYNEYFRDLNHV | 191 | P00492 | |
| FRCSAEELDYYLYGQ | 166 | Q9NQX0 | |
| TRYLENQTFRFDYAF | 266 | O00139 | |
| YSYRYLINSYDFVND | 46 | Q9BYG0 | |
| RYKLQDFSDQLSDYY | 4496 | P04114 | |
| LAYDVYNNSDLFYRE | 101 | Q9BXC9 | |
| TQNLHSYFAERLYYA | 251 | Q5VT79 | |
| QFYYSEFLDSVAAIY | 146 | Q9H6J7 | |
| NRFDLNTSYYIFLAD | 316 | Q6ZNA5 | |
| LYYAESDLDYGTNFQ | 121 | P29317 | |
| QYSDRTRPEFYLNSY | 1071 | P12111 | |
| YLRLYETAVEFSSNY | 766 | Q8WXX0 | |
| GLIQDSYYRFNDLNY | 56 | O00462 | |
| DRYFTIFYALQYHNI | 146 | P32245 | |
| ELYALYDQFYVANEF | 311 | Q14314 | |
| QDRDDLYFYIATYLE | 276 | Q92636 | |
| TFLYNELYVYNTRKD | 91 | Q8TBB5 | |
| EDDLYYYNFTRTVIS | 2676 | Q03164 | |
| LTYLNARSSRDFEYY | 121 | Q8IWA5 | |
| YSDRYIFASNLYESE | 131 | P27707 | |
| RFFNQLYAGLDYYSL | 116 | Q6ZQY3 | |
| SYYQSSVQYLYRELL | 781 | Q86Y56 | |
| ARYLDLFTNYISLYN | 46 | P24390 | |
| LEDALYSEYLYQEQY | 126 | Q99675 | |
| SYIVSYYLRNFDEDA | 1536 | Q9NZ56 | |
| YTSRYYLKFNFLEQA | 266 | Q96CX2 | |
| ENELLFYYSRDYAQQ | 521 | Q9UKN5 | |
| NYYSSRFSPDSQYID | 376 | Q8TEW0 | |
| DQYQFSYRAALEYLG | 1891 | P23468 | |
| SYIEIYNNYIYDLLE | 221 | Q02241 | |
| SASIYNYNINTYARF | 2871 | Q6ZRI0 | |
| YVYFENSSSNPYLIR | 11 | Q9BTC8 | |
| EQASYDVSRYENIFY | 301 | A8MW99 | |
| VAYLEQLNSENYSIY | 526 | Q86VV8 | |
| SYNYLIRYLQSDNNT | 171 | O75529 | |
| AYSTVSRFFLYRLNY | 406 | Q969X6 | |
| ASYYVSYRREAFAQI | 411 | Q9UPU3 | |
| LLENFYADYYTTASI | 461 | A1A5C7 | |
| TLYNYASNQREEYLL | 921 | Q13576 | |
| EYQLNDSAAYYLNDL | 146 | P04899 | |
| LYSDDTVESYQLSYR | 396 | A1L4K1 | |
| ERAAEYQLNDSASYY | 141 | P19087 | |
| YQLNDSASYYLNQLE | 146 | P19087 | |
| LEYLQADYNYISAIE | 136 | Q9H156 | |
| YYRNLQEFSYSNLEE | 711 | Q9H156 | |
| ALQLERISVYYNEAY | 41 | Q9H4B7 | |
| VADYLTSQFYALNYS | 591 | Q9Y4R8 | |
| TRDYVYNFTYNSEGD | 1561 | Q9UKZ4 | |
| DRFAYCATLAIYIYQ | 51 | Q8IZU2 | |
| YVYFENSSSNPYLIR | 11 | Q13330 | |
| YASRGDLYDYISERQ | 131 | Q9H093 | |
| QESPYLFSYRNSNYL | 336 | Q6P1J6 | |
| SILELYNYFEDSNYV | 71 | O00444 | |
| YVYNDGYLLNYDLSV | 491 | Q6UX06 | |
| SSLEYYSFYDDRQKR | 651 | Q9Y5Q9 | |
| YEDNSLYQLFYLANL | 326 | Q9HAY6 | |
| ETSLYYLLSNNYVNS | 111 | Q2KHT3 | |
| TNYRLYAYTESELQI | 311 | Q92759 | |
| EAASYLDQISRYYIT | 171 | P61289 | |
| TYDHYRFFQQYPSNL | 301 | Q32MQ0 | |
| SYNLALAYYSSRQYA | 191 | Q8N4P2 | |
| TYRDFQQALYELSYH | 41 | Q8NI27 | |
| NYRNLVSLAVYSYYN | 36 | Q8TB69 | |
| NFLNYDLTLRCDYYG | 316 | Q9H3R2 | |
| LNSAIIYDRDFSYNY | 131 | P23921 | |
| DRYYNEAGISLYLAQ | 991 | Q96MS0 | |
| EAESAYRNALYYRSN | 511 | Q8N394 | |
| FYNLYTLDYDVALLE | 906 | Q7Z410 | |
| LRNQLYESYYLNFIS | 106 | Q8WVM8 | |
| YESYYLNFISAISRS | 111 | Q8WVM8 | |
| DYFTLLRHLLNYAYN | 1376 | O00507 | |
| RNDNYSSYNNVYLAV | 591 | Q5HYM0 | |
| SYNLALAYYSSRQYA | 191 | Q86WT1 | |
| FYQALDDRLYCVYQS | 46 | Q9NUQ2 | |
| NAVLYTNRAAAQYYL | 116 | O95801 | |
| FYYVFEISETYNRLA | 56 | Q8N6I4 | |
| QRELFYILLAYSEYN | 166 | P35125 | |
| QFTLSEETNADVYYY | 476 | Q86Y07 | |
| SFNYLDLYRLADLFN | 141 | Q96NJ5 | |
| ADNIKSFEDRYDYYS | 216 | Q6P5S2 | |
| LSRNIYSADYYKANE | 746 | O15146 | |
| SEDSLYNDYVDVFYN | 716 | P29120 |